Pharmaceutical products of moxonidine and hydrochlorothiazide

Details Pharmaceutical products of moxonidine and hydrochlorothiazide Pharmaceutical products of moxonidine and hydrochlorothiazide

1988-11-17

1990-08-28

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424400, 424436, 424456, 424464, 424479, 424489, 514869, A61K 920

Patent

active

049524100

ABSTRACT:
Pharmaceutical composition containing moxonidine (4-chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)aminopyrimidine) or its pharmaceutically acceptable salts and hydrochlorothiazide (6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulphonamide-1,1-dioxide ) and, if appropriate, triamterene (2,4,7-triamino-6-phenylpteridine).

REFERENCES:
patent: 3113075 (1963-12-01), Bicking et al.
patent: 4075208 (1978-02-01), Wilhelm et al.
patent: 4255433 (1981-03-01), Herrmann et al.
patent: 4681765 (1987-07-01), Guley
patent: 4793999 (1988-12-01), Sheth

Affiliated with

Also associated with

Rating

Pharmaceutical products of moxonidine and hydrochlorothiazide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical products of moxonidine and hydrochlorothiazide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical products of moxonidine and hydrochlorothiazide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1588807